Paired transcriptomics of glioblastoma peripheral and core areas reveals CNTN2 as a potential therapeutic target

Larroquette M, Sarnow K, Meloni M, Rudewicz J, Dartigues B, Epinette E, Guyon J, Larrieu CM, Solda G, Bjerkvig R, Engelhardt J, Martin OC, Bello L, Nikolski M, Heiland DH, Rossi M, Daubon T (2026)

Publication Type: Journal article

Publication year: 2026

Journal

Cancer Letters Elsevier

Book Volume: 654

Article Number: 218552

DOI: 10.1016/j.canlet.2026.218552

Authors with CRIS profile

Dieter Henrik Heiland Professur für Translationale Neurochirurgie (Heisenberg-Professur)

Involved external institutions

Centre Hospitalier Universitaire de Bordeaux / CHU Bordeaux FR France (FR) Université de Bordeaux FR France (FR) University of Bergen / Universitetet i Bergen NO Norway (NO) Università degli studi di Milano IT Italy (IT) Istituto Ortopedico Galeazzi IT Italy (IT) Humanitas University IT Italy (IT)

How to cite

APA:

Larroquette, M., Sarnow, K., Meloni, M., Rudewicz, J., Dartigues, B., Epinette, E.,... Daubon, T. (2026). Paired transcriptomics of glioblastoma peripheral and core areas reveals CNTN2 as a potential therapeutic target. Cancer Letters, 654. https://doi.org/10.1016/j.canlet.2026.218552

MLA:

Larroquette, Mathieu, et al. "Paired transcriptomics of glioblastoma peripheral and core areas reveals CNTN2 as a potential therapeutic target." Cancer Letters 654 (2026).

BibTeX: Download